BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 29614006)

  • 1. Rapid CRISPR/Cas9-Mediated Cloning of Full-Length Epstein-Barr Virus Genomes from Latently Infected Cells.
    Yajima M; Ikuta K; Kanda T
    Viruses; 2018 Apr; 10(4):. PubMed ID: 29614006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly Efficient CRISPR/Cas9-Mediated Cloning and Functional Characterization of Gastric Cancer-Derived Epstein-Barr Virus Strains.
    Kanda T; Furuse Y; Oshitani H; Kiyono T
    J Virol; 2016 May; 90(9):4383-93. PubMed ID: 26889033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A global phylogenetic analysis of Japanese tonsil-derived Epstein-Barr virus strains using viral whole-genome cloning and long-read sequencing.
    Yajima M; Kakuta R; Saito Y; Kitaya S; Toyoda A; Ikuta K; Yasuda J; Ohta N; Kanda T
    J Gen Virol; 2021 Mar; 102(3):. PubMed ID: 33433312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutagenesis and Genome Engineering of Epstein-Barr Virus in Cultured Human Cells by CRISPR/Cas9.
    Yuen KS; Chan CP; Kok KH; Jin DY
    Methods Mol Biol; 2017; 1498():23-31. PubMed ID: 27709566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential Application of the CRISPR/Cas9 System against Herpesvirus Infections.
    Chen YC; Sheng J; Trang P; Liu F
    Viruses; 2018 May; 10(6):. PubMed ID: 29844277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of Epstein-Barr virus DNA load in latently infected nasopharyngeal carcinoma cells by CRISPR/Cas9.
    Yuen KS; Wang ZM; Wong NM; Zhang ZQ; Cheng TF; Lui WY; Chan CP; Jin DY
    Virus Res; 2018 Jan; 244():296-303. PubMed ID: 28456574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr Virus BKRF4 Gene Product Is Required for Efficient Progeny Production.
    Masud HMAA; Watanabe T; Yoshida M; Sato Y; Goshima F; Kimura H; Murata T
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28904200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Gene modification in the genome of Epstein-Barr virus cloned as a bacterial artificial chromosome].
    Lu J; Tang Y; Zhou M; Wu M; Ouyang J; Gao J; Zhang L; Li D; Chen Q; Xiong W; Li X; Tang K; Li G
    Wei Sheng Wu Xue Bao; 2008 Mar; 48(3):385-90. PubMed ID: 18479068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and Cloning of a New Western Epstein-Barr Virus Strain That Efficiently Replicates in Primary B Cells.
    Delecluse S; Poirey R; Zeier M; Schnitzler P; Behrends U; Tsai MH; Delecluse HJ
    J Virol; 2020 May; 94(10):. PubMed ID: 32102884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR/Cas9-Mediated Genome Editing of Herpesviruses Limits Productive and Latent Infections.
    van Diemen FR; Kruse EM; Hooykaas MJ; Bruggeling CE; Schürch AC; van Ham PM; Imhof SM; Nijhuis M; Wiertz EJ; Lebbink RJ
    PLoS Pathog; 2016 Jun; 12(6):e1005701. PubMed ID: 27362483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of viral recombinants to the study of the immune response against the Epstein-Barr virus.
    Delecluse HJ; Feederle R; Behrends U; Mautner J
    Semin Cancer Biol; 2008 Dec; 18(6):409-15. PubMed ID: 18938248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early Epstein-Barr Virus Genomic Diversity and Convergence toward the B95.8 Genome in Primary Infection.
    Weiss ER; Lamers SL; Henderson JL; Melnikov A; Somasundaran M; Garber M; Selin L; Nusbaum C; Luzuriaga K
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29093087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From Conventional to Next Generation Sequencing of Epstein-Barr Virus Genomes.
    Kwok H; Chiang AK
    Viruses; 2016 Feb; 8(3):60. PubMed ID: 26927157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A precise excision of the complete Epstein-Barr virus genome in a plasmid based on a bacterial artificial chromosome.
    Yu Z; Lu J; Yu H; Yan Q; Zuo L; Li G
    J Virol Methods; 2011 Sep; 176(1-2):103-7. PubMed ID: 21723326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unexpected instability of family of repeats (FR), the critical cis-acting sequence required for EBV latent infection, in EBV-BAC systems.
    Kanda T; Shibata S; Saito S; Murata T; Isomura H; Yoshiyama H; Takada K; Tsurumi T
    PLoS One; 2011; 6(11):e27758. PubMed ID: 22114684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early events associated with infection of Epstein-Barr virus infection of primary B-cells.
    Halder S; Murakami M; Verma SC; Kumar P; Yi F; Robertson ES
    PLoS One; 2009 Sep; 4(9):e7214. PubMed ID: 19784370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of Epstein-Barr Virus Genomes and Expression Profiles in Gastric Adenocarcinoma.
    Borozan I; Zapatka M; Frappier L; Ferretti V
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29093097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phylogenetic comparison of Epstein-Barr virus genomes.
    Choi SJ; Jung SW; Huh S; Cho H; Kang H
    J Microbiol; 2018 Aug; 56(8):525-533. PubMed ID: 29948828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted Mutagenesis of Guinea Pig Cytomegalovirus Using CRISPR/Cas9-Mediated Gene Editing.
    Bierle CJ; Anderholm KM; Wang JB; McVoy MA; Schleiss MR
    J Virol; 2016 Aug; 90(15):6989-6998. PubMed ID: 27226370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation and precise modification of a herpesvirus saimiri bacterial artificial chromosome demonstrates that the terminal repeats are required for both virus production and episomal persistence.
    White RE; Calderwood MA; Whitehouse A
    J Gen Virol; 2003 Dec; 84(Pt 12):3393-3403. PubMed ID: 14645920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.